Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer

被引:59
作者
Porta, M
Malats, N
Guarner, L
Carrato, A
Rifà, J
Salas, A
Corominas, JM
Andreu, M
Real, FX
机构
[1] Univ Autonoma Barcelona, Inst Municipal Invest Med, E-08003 Barcelona, Spain
[2] Hosp Gen Valle Hebron, Dept Gastroenterol, Barcelona, Spain
[3] Hosp Gen Elche, Dept Oncol, Alicante, Spain
[4] Hosp Son Dureta, Dept Oncol, Mallorca, Spain
[5] Hosp Mutua Terrassa, Dept Pathol, Barcelona, Spain
[6] Univ Autonoma Barcelona, Hosp Mar, Dept Pathol, E-08003 Barcelona, Spain
[7] Univ Autonoma Barcelona, Hosp Mar, Dept Gastroenterol, E-08003 Barcelona, Spain
关键词
D O I
10.1136/jech.53.11.702
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Study objective-To analyse the relation between coffee consumption and mutations in the K-ras gene in exocrine pancreatic cancer. Design-Case-case study. Consumption of coffee among cases with the activating mutation in the K-ras gene was compared with that of cases without the mutation. Setting and patients-All cases of pancreatic cancer newly diagnosed at five hospitals in Spain during three years were included in the PANKRAS II Study (n=185, of whom 121 whose tissue was available for molecular analysis are the object of the present report). Over 88% were personally interviewed in hospital. DNA was amplified from paraffin wax embedded tissues, and mutations in codon 12 of K-ras were detected by the artificial RFLP technique. Main results-Mutations were found in tumours from 94 of 121 patients (77.7%). Mutations were more common among regular coffee drinkers than among nonregular coffee drinkers (82.0% v 55.6%, p=0.018, n=107). The odds ratio adjusted by age, sex, smoking and alcohol drinking was 5.41 (95% CI 1.64, 17.78). The weekly intake of coffee was significantly higher among patients with a mutated tumour (mean of 14.5 cups/week v 8.8 among patients with a wild type tumour, p<0.05). With respect to non-regular coffee drinkers, the odds ratio of a mutated tumour adjusted by age, sex, smoking and alcohol drinking was 3.26 for drinkers of 2-7 cups/week, 5.77 for drinkers of 8-14 cups/week and 9.99 for drinkers of greater than or equal to 15 cups/week (p<0.01, test for trend). Conclusions-Pancreatic cancer cases without activating mutations in the K-ras gene had drank significantly less coffee than cases with a mutation, with a significant dose response relation: the less they drank, the less likely their tumours were to harbour a mutation. In exocrine pancreatic cancer the K-ras gene may be activated less often among non-regular coffee drinkers than among regular drinkers. Caffeine, other coffee compounds or other factors with which coffee drinking is associated may modulate K-ras activation.
引用
收藏
页码:702 / 709
页数:8
相关论文
共 71 条
[31]   SELF-REPORT RELIABILITY AND SYMPTOMATOLOGY OF HABITUAL CAFFEINE CONSUMPTION [J].
JAMES, JE ;
BRUCE, MS ;
LADER, MH ;
SCOTT, NR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (04) :507-514
[32]   VALIDITY OF SELF-REPORTS OF CAFFEINE USE [J].
KENNEDY, JS ;
VONMOLTKE, LL ;
HARMATZ, JS ;
ENGELHARDT, N ;
GREENBLATT, DJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (07) :677-680
[33]  
LAVECCHIA C, 1993, CAFFEINE COFFEE HLTH, P379
[34]   CAFFEINE INHIBITS GENE-SPECIFIC REPAIR OF UV-INDUCED DNA-DAMAGE IN HAMSTER-CELLS AND IN HUMAN XERODERMA-PIGMENTOSUM GROUP-C CELLS [J].
LINK, CJ ;
EVANS, MK ;
COOK, JA ;
MULDOON, R ;
STEVNSNER, T ;
BOHR, VA .
CARCINOGENESIS, 1995, 16 (05) :1149-1155
[35]   TOBACCO-SMOKE INHALATION PATTERN, TOBACCO TYPE, AND BLADDER-CANCER IN SPAIN [J].
LOPEZABENTE, G ;
GONZALEZ, CA ;
ERREZOLA, M ;
ESCOLAR, A ;
IZARZUGAZA, I ;
NEBOT, M ;
RIBOLI, E .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 134 (08) :830-839
[36]   COFFEE CONSUMPTION AND THE RISK OF CANCER OF THE EXOCRINE PANCREAS - A CASE-CONTROL STUDY IN A LOW-RISK POPULATION [J].
LYON, JL ;
MAHONEY, AW ;
FRENCH, TK ;
MOSER, R .
EPIDEMIOLOGY, 1992, 3 (02) :164-170
[37]  
MACLURE M, 1992, AM J EPIDEMIOL, V135, P96
[38]  
Malats N, 1997, INT J CANCER, V70, P661, DOI 10.1002/(SICI)1097-0215(19970317)70:6<661::AID-IJC6>3.0.CO
[39]  
2-T
[40]  
MALATS N, 1993, J NATL CANCER I, V85, P328, DOI 10.1093/jnci/85.4.328